Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUP133-DT (NUP133 divergent transcript) is annotated in genomic databases, including GeneCards and BioGPS, as a non-protein-coding RNA gene. Its specific function, biological significance, and disease relevance have not been documented in the scientific literature. The transcript does not encode a protein and is not recognized as a receptor, enzyme, transporter, or other canonical therapeutic target. If a druggable nuclear pore complex component is sought, NUP133 (Nucleoporin 133) is the relevant target, not NUP133-DT.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NUP133 divergent transcript (NUP133-DT).